Atypical MOG antibody disease presenting with typical multiple sclerosis lesions

被引:7
|
作者
Dolbec, Katelyn [1 ]
Chalkley, Joshua [1 ]
Sudhakar, Padmaja [1 ]
机构
[1] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
关键词
D O I
10.1016/j.msard.2020.102342
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myelin oligodendrocyte glycoprotein (MOG) antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, a glycoprotein expressed on the outer membrane of myelin. It is solely found within the central nervous system in the brain, optic nerves and spinal cord. MOG antibody disease falls within the neuromyelitis optica spectrum disorders (NMOSD), however clinical characteristics appear distinct from aquaporin-4 antibody related disease and multiple sclerosis. It has predilection for causing recurrent optic neuritis and transverse myelitis. Accurate diagnosis is important to determine long term prognosis and suitable treatment. We describe the case of a 42 year old woman previously labelled as MS who demonstrated a variable presentation of MOG antibody disease.
引用
收藏
页数:2
相关论文
共 50 条
  • [21] ATYPICAL DEMYELINATING LESIONS IN PATIENTS WITH MULTIPLE-SCLEROSIS
    YETKIN, Z
    HAUGHTON, VM
    NEURORADIOLOGY, 1995, 37 (04) : 284 - 286
  • [22] Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question
    De Mercanti, Stefania Federica
    Gned, Dario
    Matta, Manuela
    Iudicello, Marco
    Franchin, Emanuele
    Clerico, Marinella
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2020, 8
  • [23] Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis
    Egg, R
    Reindl, M
    Deisenhammer, F
    Linington, C
    Berger, T
    MULTIPLE SCLEROSIS JOURNAL, 2001, 7 (05) : 285 - 289
  • [24] Socioeconomic, Clinical, and Laboratory Parameters Differentiating Pediatric Patients With MOG Antibody-Associated Disease and Multiple Sclerosis
    Florenzo, Brian
    Brenton, J. Nicholas
    JOURNAL OF CHILD NEUROLOGY, 2023, 38 (3-4) : 178 - 185
  • [25] Atypical myelitis in patients with multiple sclerosis: characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders
    Bigaut, Kevin
    Cohen, Mickael
    Ciron, Jonathan
    Bourre, Bertrand
    Kerschen, Philippe
    Labauge, Pierre
    Collongues, Nicolas
    NEUROLOGY, 2020, 94 (15)
  • [26] Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders
    Bigaut, K.
    Lambert, C.
    Kremer, L.
    Lebrun, C.
    Cohen, M.
    Ciron, J.
    Bourre, B.
    Creange, A.
    Kerschen, P.
    Montcuquet, A.
    Carra-Dalliere, C.
    Ayrignac, X.
    Labauge, P.
    de Seze, J.
    Collongues, N.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (02) : 232 - 238
  • [27] MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) GENE POLYMORPHISMS AND MULTIPLE-SCLEROSIS - NO EVIDENCE OF DISEASE ASSOCIATION WITH MOG
    ROTH, MP
    DOLBOIS, L
    BOROT, N
    PONTAROTTI, P
    CLANET, M
    COPPIN, H
    JOURNAL OF NEUROIMMUNOLOGY, 1995, 61 (02) : 117 - 122
  • [28] Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease
    Mastrangelo, Vincenzo
    Asioli, Gian Maria
    Foschi, Matteo
    Padroni, Marina
    Pavolucci, Lucia
    Cenni, Patrizia
    Querzani, Pietro
    NEUROLOGY, 2020, 95 (14) : 648 - 649
  • [29] Mog antibody disease and pregnancy
    Ysrraelit, M.
    Ochoa, S.
    Farez, M.
    Correale, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 651 - 651
  • [30] MOG Antibody-Associated Disease and Thymic Hyperplasia From the National Multiple Sclerosis Society Case Conference Proceedings
    Hurtubise, Brigitte
    Frohman, Elliot M.
    Galetta, Steven
    Balcer, Laura J.
    Frohman, Teresa C.
    Lisak, Robert P.
    Newsome, Scott D.
    Graves, Jennifer S.
    Zamvil, Scott S.
    Amezcua, Lilyana
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (02):